glp-1/gip agonist GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Dual GIP/GLP-1 receptor agonists: New
Description
Some people experience nausea or other gastrointestinal effects when using GLP-1 agonists
For example, extremely high doses of magnesium are more likely to cause diarrhea, while large doses of fiber without adequate fluid can actually worsen constipation and make stool harder to pass
If you are losing weight steadily at 5mg and tolerating it well, there may be no reason to increase
Cell Signal
Assigned to tackle these questions, Drucker made a profound discovery: different organs processed proglucagonwell, differently
